BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 22361433)

  • 21. Selumetinib Attenuates Skeletal Muscle Wasting in Murine Cachexia Model through ERK Inhibition and AKT Activation.
    Quan-Jun Y; Yan H; Yong-Long H; Li-Li W; Jie L; Jin-Lu H; Jin L; Peng-Guo C; Run G; Cheng G
    Mol Cancer Ther; 2017 Feb; 16(2):334-343. PubMed ID: 27599525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Aerobic and resistance training dependent skeletal muscle plasticity in the colon-26 murine model of cancer cachexia.
    Khamoui AV; Park BS; Kim DH; Yeh MC; Oh SL; Elam ML; Jo E; Arjmandi BH; Salazar G; Grant SC; Contreras RJ; Lee WJ; Kim JS
    Metabolism; 2016 May; 65(5):685-698. PubMed ID: 27085776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation.
    Daou HN
    Am J Physiol Regul Integr Comp Physiol; 2020 Feb; 318(2):R296-R310. PubMed ID: 31823669
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia.
    Rupert JE; Narasimhan A; Jengelley DHA; Jiang Y; Liu J; Au E; Silverman LM; Sandusky G; Bonetto A; Cao S; Lu X; O'Connell TM; Liu Y; Koniaris LG; Zimmers TA
    J Exp Med; 2021 Jun; 218(6):. PubMed ID: 33851955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of PARP activity in lung cancer-induced cachexia: Effects on muscle oxidative stress, proteolysis, anabolic markers, and phenotype.
    Chacon-Cabrera A; Mateu-Jimenez M; Langohr K; Fermoselle C; García-Arumí E; Andreu AL; Yelamos J; Barreiro E
    J Cell Physiol; 2017 Dec; 232(12):3744-3761. PubMed ID: 28177129
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Group I Paks support muscle regeneration and counteract cancer-associated muscle atrophy.
    Cerquone Perpetuini A; Re Cecconi AD; Chiappa M; Martinelli GB; Fuoco C; Desiderio G; Castagnoli L; Gargioli C; Piccirillo R; Cesareni G
    J Cachexia Sarcopenia Muscle; 2018 Aug; 9(4):727-746. PubMed ID: 29781585
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Luteolin reduces cancer‑induced skeletal and cardiac muscle atrophy in a Lewis lung cancer mouse model.
    Chen T; Li B; Xu Y; Meng S; Wang Y; Jiang Y
    Oncol Rep; 2018 Aug; 40(2):1129-1137. PubMed ID: 29845270
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tissue-specific dysregulation of mitochondrial respiratory capacity and coupling control in colon-26 tumor-induced cachexia.
    Halle JL; Pena GS; Paez HG; Castro AJ; Rossiter HB; Visavadiya NP; Whitehurst MA; Khamoui AV
    Am J Physiol Regul Integr Comp Physiol; 2019 Jul; 317(1):R68-R82. PubMed ID: 31017805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FoxP1 is a transcriptional repressor associated with cancer cachexia that induces skeletal muscle wasting and weakness.
    Neyroud D; Nosacka RL; Callaway CS; Trevino JG; Hu H; Judge SM; Judge AR
    J Cachexia Sarcopenia Muscle; 2021 Apr; 12(2):421-442. PubMed ID: 33527776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. mef2c is activated directly by myogenic basic helix-loop-helix proteins during skeletal muscle development in vivo.
    Dodou E; Xu SM; Black BL
    Mech Dev; 2003 Sep; 120(9):1021-32. PubMed ID: 14550531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoplasmic Reticulum Stress, Calcium Dysregulation and Altered Protein Translation: Intersection of Processes That Contribute to Cancer Cachexia Induced Skeletal Muscle Wasting.
    Isaac ST; Tan TC; Polly P
    Curr Drug Targets; 2016; 17(10):1140-6. PubMed ID: 25882219
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Necdin is expressed in cachectic skeletal muscle to protect fibers from tumor-induced wasting.
    Sciorati C; Touvier T; Buono R; Pessina P; François S; Perrotta C; Meneveri R; Clementi E; Brunelli S
    J Cell Sci; 2009 Apr; 122(Pt 8):1119-25. PubMed ID: 19339547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model.
    Tzika AA; Fontes-Oliveira CC; Shestov AA; Constantinou C; Psychogios N; Righi V; Mintzopoulos D; Busquets S; Lopez-Soriano FJ; Milot S; Lepine F; Mindrinos MN; Rahme LG; Argiles JM
    Int J Oncol; 2013 Sep; 43(3):886-94. PubMed ID: 23817738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic derangements of skeletal muscle from a murine model of glioma cachexia.
    Cui P; Shao W; Huang C; Wu CJ; Jiang B; Lin D
    Skelet Muscle; 2019 Jan; 9(1):3. PubMed ID: 30635036
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Muscle and serum metabolomes are dysregulated in colon-26 tumor-bearing mice despite amelioration of cachexia with activin receptor type 2B ligand blockade.
    Lautaoja JH; Lalowski M; Nissinen TA; Hentilä J; Shi Y; Ritvos O; Cheng S; Hulmi JJ
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E852-E865. PubMed ID: 30860875
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myostatin regulates fiber-type composition of skeletal muscle by regulating MEF2 and MyoD gene expression.
    Hennebry A; Berry C; Siriett V; O'Callaghan P; Chau L; Watson T; Sharma M; Kambadur R
    Am J Physiol Cell Physiol; 2009 Mar; 296(3):C525-34. PubMed ID: 19129464
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NF-kappaB-induced loss of MyoD messenger RNA: possible role in muscle decay and cachexia.
    Guttridge DC; Mayo MW; Madrid LV; Wang CY; Baldwin AS
    Science; 2000 Sep; 289(5488):2363-6. PubMed ID: 11009425
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Calcineurin activates interleukin-6 transcription in mouse skeletal muscle in vivo and in C2C12 myotubes in vitro.
    Allen DL; Uyenishi JJ; Cleary AS; Mehan RS; Lindsay SF; Reed JM
    Am J Physiol Regul Integr Comp Physiol; 2010 Jan; 298(1):R198-210. PubMed ID: 19907005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice.
    Molinari F; Pin F; Gorini S; Chiandotto S; Pontecorvo L; Penna F; Rizzuto E; Pisu S; Musarò A; Costelli P; Rosano G; Ferraro E
    J Cachexia Sarcopenia Muscle; 2017 Dec; 8(6):954-973. PubMed ID: 29130633
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The steroid receptor coactivator, GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle differentiation.
    Chen SL; Dowhan DH; Hosking BM; Muscat GE
    Genes Dev; 2000 May; 14(10):1209-28. PubMed ID: 10817756
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.